NEU
- It's drug has enabled complete treatment of Angelman Syndrome and PTHS in a pre-clinical model, where there is no current treatment available.
- Should go up to $2-3 today, should have a fomo run maybe in the afternoon, like we saw with OCC when they released its announcement.
- Biotech sector's hot, stock was trading almost $4 not too long ago
- Forums
- ASX - Day Trading
- morning traders 17 / 05
morning traders 17 / 05, page-162
-
- There are more pages in this discussion • 205 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)